1. Home
  2. > Pharmaceutical
  3. > Biopharmaceutical Market Trends
Mesenchymal Stem Cells Market Report 2022-2032

Mesenchymal Stem Cells Market Report 2022-2032

  • September 2022
  • 282 pages
  • ID: 6321436
  • Format: PDF
  • Visiongain Reports Ltd.

Summary

Table of Contents

Forecasts by Type (Product (Cell and Cell Lines, Kits Media and Reagents, Others), Services), by Source (Bone Marrow, Adipose Tissue, Cord Blood, Fallopian Tube, Foetal Liver, Lung, Peripheral Blood, Other), by Indication (Bone and Cartilage Repair, cardiovascular Disease, Cancer, GvHD, Inflammatory and Immunological Diseases, Liver Diseases, Other), by Application (Disease Modelling, Drug Discovery and Development, Stem Cell Banking, Tissue Engineering, Toxicology Studies, Other) AND Regional and Leading National Market Analysis PLUS Analysis of Leading Companies AND COVID-19 Impact and Recovery Pattern Analysis

The Mesenchymal Stem Cells Market Report 2022-2032: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.

Factors Such As Application In Various Therapy Areas and Rising Number of Clinical Trials are Driving the Market Growth

Some of the major factors propelling the mesenchymal stem cells market include wide application of Mesenchymal stem cells in a range of fields, including haematological disease, graft-versus-host disease, organ transplantation, diabetes, inflammatory diseases, and diseases in the liver, kidney, and lung, as well as cardiovascular, bone and cartilage, neurological, and autoimmune diseases. Increasing number of clinical trials in mesenchymal stem cell-based therapies is one of the major factors driving the market. The number of new reported phase I and II MSC clinical trials have expanded consistently over the past fifteen years and Increasing investment and funding for mesenchymal stem cell research and rising incidence of orthopaedic disorder and increase in cancer incidences are anticipated to support the global market growth

Challenges in Technology Transfer and Limited Expansion of Mesenchymal Stem Cells

Transferring of MSCs from bench to bedside is theoretically highly attainable, however, many failures have been reported in clinical trials, resulting in FDA rejection. Heterogeneity of MSCs from donors arise due to factors such as age, gender, genetic makeup and medical health condition. It has been also observed that there is difference in the differentiation capacities and the degree of stemness between mesenchymal stem cells isolated from different sources such as adipose tissue, bone marrow, muscles and umbilical cord. Inconsistency in further expansion capacities such as culture conditions, flasks / bioreactors passage number, oxygen levels, and cell surface modifications. Moreover MSCs also have the ability to differentiate into various cell types such as hepatocyte, neural cells and pancreatic islet cells. Hence, there are fair chances that in vitro induction of MSCs would not yield pure competent cells needed for the treatment of the disease.


What Questions Should You Ask before Buying a Market Research Report?

• How is the mesenchymal stem cells market evolving?

• What is driving and restraining the mesenchymal stem cells market?

• How will each mesenchymal stem cells submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2032?

• How will the market shares for each mesenchymal stem cells submarket develop from 2022 to 2032?

• What will be the main driver for the overall market from 2022 to 2032?

• Will leading mesenchymal stem cells markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?

• How will the market shares of the national markets change by 2032 and which geographical region will lead the market in 2032?

• Who are the leading players and what are their prospects over the forecast period?

• What are the mesenchymal stem cells projects for these leading companies?

• How will the industry evolve during the period between 2022 and 2032? What are the implications of mesenchymal stem cells projects taking place now and over the next 10 years?

• Is there a greater need for product commercialisation to further scale the mesenchymal stem cells market?

• Where is the mesenchymal stem cells market heading and how can you ensure you are at the forefront of the market?

• What are the best investment options for new product and service lines?

• What are the key prospects for moving companies into a new growth path and C-suite?


You need to discover how this will impact the mesenchymal stem cells market today, and over the next 10 years:

• Our 282-page report provides 117 tables and 184 charts/graphs exclusively to you.

• The report highlights key lucrative areas in the industry so you can target them – NOW.

• It contains in-depth analysis of global, regional and national sales and growth.

• It highlights for you the key successful trends, changes and revenue projections made by your competitors.


This report tells you TODAY how the Mesenchymal Stem Cells market will develop in the next 10 years, and in line with the variations in COVID-19 economic recession and bounce. This market is more critical now than at any point over the last 10 years.


Forecasts to 2032 and other analyses reveal commercial prospects

• In addition to revenue forecasting to 2032, our new study provides you with recent results, growth rates, and market shares.

• You will find original analyses, with business outlooks and developments.

• Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), cost structure, impact of rising investment in mesenchymal stem cells and recent developments.


This report includes data analysis and invaluable insight into how COVID-19 will affect the industry and your company. Four COVID-19 recovery patterns and their impact, namely, “V”, “L”, “W” and “U” are discussed in this report.


Segments Covered in the Report


Type

• Products

- Cell and Cell Lines

- Kits Media and Reagents

- Others

• Service


Source

• Bone marrow

• Adipose Tissue

• Cord Blood

• Fetal Liver

• Lung

• Peripheral Blood

• Fallopian Tube

• Other Sources


Indication

• Bone and cartilage Repair

• Cardiovascular Disease

• Cancer

• GvHD

• Inflammatory and Immunological Diseases

• Liver Diseases

• Other Indication


Application

• Disease Modelling

• Drug Discovery and Development

• Stemcell Banking

• Tissue Engineering

• Toxicology Studies

• Others


In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for five regional and 17 leading national markets:


North America

• U.S.

• Canada


Europe

• Germany

• UK

• France

• Spain

• Italy

• Rest of Europe


Asia Pacific

• China

• Japan

• India

• Australia

• Rest of Asia Pacific


Latin America

• Brazil

• Mexico

• Argentina

• Rest of Latin America


MEA

• Saudi Arabia

• South Africa

• Turkey

• Rest of MEA


The report also includes profiles and for some of the leading companies in the Mesenchymal Stem Cells Market, 2022 to 2032, with a focus on this segment of these companies’ operations.


Leading companies and the potential for market growth

• Cell Application Inc.

• Celltex Therapeutics Corporation.

• Celprogen Inc.

• Cyagen Biosciences

• Cytori Therapeutics Inc. (Plus Therapeutics Inc.)

• Lonza

• Merck KGaA (Millipore Sigma)

• PromoCell GmbH

• STEMCELL Technologies Inc.

• Stemedica Cell Technologies Inc.

• Thermo Fischer Scientific Inc.


Overall global revenue for Mesenchymal Stem Cells Market, 2022 to 2032 in terms of value the market will surpass US$2.75 billion in 2022, our work calculates. We predict strong revenue growth through to 2032. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.


How will the Mesenchymal Stem Cells Market, 2022 to 2032 report help you?

In summary, our 280+ page report provides you with the following knowledge:


• Revenue forecasts to 2032 for Mesenchymal Stem Cells Market, 2022 to 2032 Market, with forecasts for Type, Source, Indication and Application, each forecast at a global and regional level – discover the industry’s prospects, finding the most lucrative places for investments and revenues.


• Revenue forecasts to 2032 for five regional and 17 key national markets – See forecasts for the Mesenchymal Stem Cells Market, 2022 to 2032 market in North America, Europe, Asia-Pacific and LATAM and MEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.


• Prospects for established firms and those seeking to enter the market – including company profiles for 11 of the major companies involved in the Mesenchymal Stem Cells Market, 2022 to 2032.



Please note: This report is accessed through a password system. Single user (non-printable) and departmental licenses expires after 12 month period.


Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

ReportLinker may already be registered as a supplier with your company. If you want to Order by PO, check with us first and we'll let you know if we are a registered supplier and what the vendor number is. Otherwise, we'll provide you with the necessary information to register ReportLinker as a vendor.

Grace helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at [email protected] to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - [email protected] or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers

Gene Synthesis Market Research Report by Method, Gene Type, Service, Application, End-use, Region - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030

  • $ 3949
  • January 2023
  • 229 pages

Gene Synthesis Market Research Report by Method (Chip-Based Synthesis, PCR-Based Enzyme Synthesis, and Solid-Phase Synthesis), Gene Type, Service, Application, End-use, Region - Cumulative Impact of COVID-19, ...

  • World
  • Pharmaceutical
  • Marketing Research
  • Industry analysis

ref:plp2022

Reportlinker.com © Copyright 2023. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on